How to Help Constipation on Mounjaro: What the Evidence Says

Why tirzepatide causes constipation, and when it tends to ease

Mounjaro works partly by activating GIP and GLP-1 receptors that slow the rate at which food leaves the stomach. That slower transit extends down the digestive tract, giving the bowel more time to draw water from its contents. The result is stools that are harder and less frequent. This is not a sign that treatment is failing. The SURMOUNT clinical programme (which enrolled thousands of adults over 72 weeks) recorded constipation among the most commonly reported gastrointestinal events, sitting alongside nausea and diarrhoea in the published side-effect profile.

For most people the pattern is predictable: symptoms are most noticeable in the first few weeks of a new dose and ease as the body adjusts. If you have started at 2.5 mg and found constipation settled before your next dose step, that experience tends to repeat at each increase, though less intensely for many patients. If you want a closer look at how Mounjaro constipation develops and what drives it, that is covered in its own dedicated guide. A useful background read on the full side-effect picture is our Mounjaro side-effects page, which covers the wider GI profile in context.

The prescriber's job is to balance therapeutic progress with tolerability, slowing a titration step is a legitimate clinical option if constipation is causing real difficulty. Never adjust your dose schedule without speaking to your prescribing team first.

What actually helps constipation while on Mounjaro

The practical steps that reduce constipation on tirzepatide are the same ones that work generally, but they carry extra weight here because slowed transit makes the baseline more demanding. Fluid intake matters most: aim for around 1.5 to 2 litres of water across the day, because the bowel is drawing more water from contents than it would at normal transit speed. Caffeine-heavy drinks do not substitute well, plain water and diluted no-added-sugar options are preferable.

Dietary fibre helps, with a real caveat: introducing large amounts of fibre quickly when you are already constipated can worsen bloating and discomfort. A gradual increase (adding a portion of vegetables, pulses or wholegrains to one meal at a time) tends to work better than an overnight overhaul. The NHS Live Well healthy-weight guidance has practical food-planning advice that applies alongside treatment.

Light movement helps too. Gentle walking after meals encourages peristalsis (the wave-like muscle contractions that move food along). Sitting for long stretches slows an already slowed system further. If lifestyle adjustments are not enough after a week or two, over-the-counter osmotic laxatives such as macrogol (available at a pharmacy) are generally considered appropriate alongside tirzepatide, but check with your prescriber or pharmacist before starting any new medicine. Our guide on how to stop constipation on Mounjaro walks through these approaches in more detail, and more on prevention strategies is covered in our guide on how to avoid constipation on Mounjaro.

When constipation on Mounjaro needs medical attention

Most constipation on tirzepatide is uncomfortable but not dangerous. There are exceptions, and it is important to know them. Seek urgent medical help if you experience severe abdominal pain, particularly pain that is persistent or that spreads to your back, with or without vomiting. In January 2026 the MHRA issued a Drug Safety Update highlighting acute pancreatitis as a known but infrequent serious side effect of GLP-1 medicines, and its presenting symptoms can overlap with severe constipation-related discomfort. The key difference is severity and radiation: ordinary constipation does not typically cause the kind of intense, spreading pain associated with pancreatitis. Do not try to manage that pattern at home.

Other reasons to contact your GP or prescriber promptly include constipation lasting more than a week with no improvement despite lifestyle changes, any rectal bleeding, signs of dehydration from vomiting alongside constipation, or a sudden change in bowel habits that feels different from the pattern you have come to know. The full picture of what causes constipation on Mounjaro and how frequently it occurs is covered in its own detailed guide if you want the clinical background.

You can report any side effect you think may be related to tirzepatide (including persistent or unusual constipation) through the MHRA's Yellow Card scheme. Patient reports actively inform ongoing safety monitoring for medicines under additional surveillance, and Mounjaro carries the Black Triangle (▼) mark for that reason.

Constipation, Mounjaro and the consultation at nume

Side effects are a central part of the clinical conversation, not an afterthought. When a prescriber reviews a consultation at our pharmacy, they are reading about your health history, any existing bowel conditions, current medicines and how you are tolerating treatment, not scanning for a tick-box approval. That review happens the same day a consultation is submitted. A real clinician reads it, not software.

If you are already on Mounjaro and constipation is an ongoing problem, your prescribing team is the right first contact. If you are considering treatment and want to understand the full side-effect profile before deciding, our prescribers discuss exactly that as part of the consultation. Mounjaro is a prescription-only medicine; clinical assessment establishes whether it is suitable for you. Once approved, the pen arrives via DPD the next working day in plain, unbranded packaging, with tracking so you are not waiting around wondering. You can explore what treatment involves on our weight-loss treatments page or read the broader context on Mounjaro and how it works.

Eligibility and side-effect management are best assessed together. Check your eligibility and speak to our prescribers as part of the free consultation.